CPH 0.00% 0.9¢ creso pharma limited

Ann: Halucenex secures agreement with R&D partner Nucro-Technics, page-2

  1. 826 Posts.
    lightbulb Created with Sketch. 437
    When is the Dual Listing in the US?
 
watchlist Created with Sketch. Add CPH (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.